BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9260590)

  • 1. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
    Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
    J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
    Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
    Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
    Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.
    Tanaka T; Konno H; Matsuda I; Nakamura S; Baba S
    Cancer Res; 1995 Feb; 55(4):836-9. PubMed ID: 7531615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.
    Qin LX; Tang ZY; Li XM; Bu W; Xia JL
    Ann Acad Med Singap; 1999 Jan; 28(1):147-51. PubMed ID: 10374041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
    Konno H; Tanaka T; Matsuda I; Kanai T; Maruo Y; Nishino N; Nakamura S; Baba S
    Int J Cancer; 1995 Apr; 61(2):268-71. PubMed ID: 7535757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy.
    Konno H
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S85-9. PubMed ID: 10357565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma.
    Fujioka T; Hasegawa M; Ogiu K; Matsushita Y; Sato M; Kubo T
    J Urol; 1996 May; 155(5):1775-8. PubMed ID: 8627882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
    Takei H; Lee ES; Cisneros A; Jordan VC
    Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice.
    Kanai T; Konno H; Tanaka T; Matsumoto K; Baba M; Nakamura S; Baba S
    Int J Cancer; 1997 May; 71(5):838-41. PubMed ID: 9180154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
    Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
    Kato T; Sato K; Kakinuma H; Matsuda Y
    Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.
    Taki T; Ohnishi T; Arita N; Hiraga S; Saitoh Y; Izumoto S; Mori K; Hayakawa T
    J Neurooncol; 1994; 19(3):251-8. PubMed ID: 7807176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.